Literature DB >> 2905503

Chronic administration of a selective dopamine D-2 agonist: factors determining behavioral tolerance and sensitization.

M T Martin-Iverson1, S M Stahl, S D Iversen.   

Abstract

The locomotor stimulant effects of sustained administration of a potent and selective dopamine (DA) D-2 receptor agonist, [+]-4-propyl-9-hydroxynaphthoxazine (PHNO), in rats were assessed 24 h a day during 12 h light-dark cycles. PHNO was administered continuously with subcutaneous implants of Alzet osmotic minipumps (5 micrograms/h), for 12 h a day with modified osmotic minipumps (5 micrograms/h), or by daily injections (15 micrograms, SC). Tolerance was observed to occur only with 24 h continuous infusions and only during the light period. The other treatment regimens produced sensitization of the locomotor response. Daytime tolerance to continuous infusions of PHNO was reversed following reversal of the light-dark cycle. A normally 'arousing' stimulus also reversed (temporarily) daytime tolerance. The present results indicate that the temporal pattern of administration of DA agonists, the phase of the circadian cycle and environmental stimuli associated with arousal are important determinants of the behavioral consequences of long-term treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905503     DOI: 10.1007/BF00172969

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Rapid decline of stereotyped behavior in rats during constant one week administration of amphetamine via implanted ALZET osmotic minipumps.

Authors:  E B Nielsen
Journal:  Pharmacol Biochem Behav       Date:  1981-08       Impact factor: 3.533

2.  Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.

Authors:  E J Hess; L J Albers; H Le; I Creese
Journal:  J Pharmacol Exp Ther       Date:  1986-09       Impact factor: 4.030

3.  SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.

Authors:  G R Breese; R A Mueller
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

4.  Effects of chronic intermittent and continuous amphetamine administration on acoustic startle.

Authors:  L Kokkinidis
Journal:  Pharmacol Biochem Behav       Date:  1984-03       Impact factor: 3.533

5.  Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists.

Authors:  A G Molloy; K M O'Boyle; M T Pugh; J L Waddington
Journal:  Pharmacol Biochem Behav       Date:  1986-07       Impact factor: 3.533

6.  Simultaneous monitoring of dopamine release in rat frontal cortex, nucleus accumbens and striatum: effect of drugs, circadian changes and correlations with motor activity.

Authors:  R D O'Neill; M Fillenz
Journal:  Neuroscience       Date:  1985-09       Impact factor: 3.590

7.  Control of on/off phenomenon by continuous intravenous infusion of levodopa.

Authors:  N Quinn; J D Parkes; C D Marsden
Journal:  Neurology       Date:  1984-09       Impact factor: 9.910

8.  L-dopa reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum.

Authors:  M Guttman; P Seeman
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

9.  Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval.

Authors:  R Castro; P Abreu; C H Calzadilla; M Rodriguez
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Responsiveness to 'autoreceptor' doses of apomorphine inversely correlated with the firing rate of dopaminergic A9 neurons: action of baclofen.

Authors:  G Mereu; F Muntoni; P Calabresi; F Romani; V Boi; G L Gessa
Journal:  Neurosci Lett       Date:  1986-04-11       Impact factor: 3.046

View more
  10 in total

1.  Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.

Authors:  S Tai; W S Hyatt; C Gu; L N Franks; T Vasiljevik; L K Brents; P L Prather; W E Fantegrossi
Journal:  Pharmacol Res       Date:  2015-09-08       Impact factor: 7.658

Review 2.  Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.

Authors:  G B Baker; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

3.  Chronic treatment with D1 and D2 dopamine receptor agonists: combined treatments interact to differentially affect brain levels of monoamines.

Authors:  M T Martin-Iverson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

4.  Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism.

Authors:  H Szechtman; H Talangbayan; G Canaran; H Dai; D Eilam
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

5.  Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia.

Authors:  M Papp; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Effects of nimodipine and/or haloperidol on the expression of conditioned locomotion and sensitization to cocaine in rats.

Authors:  M T Martin-Iverson; A R Reimer
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

Review 7.  Behavioral sensitization and tolerance to cocaine and the occupation of dopamine receptors by dopamine.

Authors:  M T Martin-Iverson; L Y Burger
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

8.  Contribution of drug doses and conditioning periods to psychomotor stimulant sensitization.

Authors:  Mark S Todtenkopf; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2006-03-21       Impact factor: 4.530

9.  Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidate.

Authors:  S J Wanchoo; A C Swann; N Dafny
Journal:  Brain Res       Date:  2009-09-09       Impact factor: 3.252

10.  Nimodipine and haloperidol attenuate behavioural sensitization to cocaine but only nimodipine blocks the establishment of conditioned locomotion induced by cocaine.

Authors:  A R Reimer; M T Martin-Iverson
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.